November 15, 2011 — A clinical trial comparing prasugrel to clopidogrel for patients with high on-clopidogrel platelet ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
November 15, 2011 — Results of ADAPT-DES (Assessment of Dual AntiPlatelet Therapy with Drug-Eluting Stents) were ...
November 15, 2011
November 15, 2011 — Data from the BRIDGE clinical trial demonstrate that intravenous use of the drug cangrelor was ...
November 15, 2011
November 11, 2011 — The 30-day results from the 8,500+ patient ADAPT-DES registry were presented at the 2011 TCT ...
November 11, 2011November 9, 2011 – AstraZeneca announced that a combined expert committee of American College of Cardiology Foundation ...
November 09, 2011
November 9, 2011 — Janssen Pharmaceuticals Inc. announced the U.S. Food and Drug Administration (FDA) has approved ...
November 09, 2011
October 24, 2011 — A new study demonstrates that angiotensin-converting enzyme (ACE) inhibitors taken in the first ...
October 24, 2011October 4, 2011 – Roche announced plans today to expand its coagulation testing product line in North America beyond ...
October 04, 2011
September 28, 2011 — A clinical trial by Resverlogix Corp. is evaluating the early effects of a new drug compound in ...
September 28, 2011
September 8, 2011 – A randomized multicenter, open-label study evaluating the efficacy and safety of prolonged ...
September 08, 2011September 8, 2011 – Patients at a high risk for a second stroke who received intensive medical treatment had fewer ...
September 08, 2011
September 6, 2011 — The European Society of Cardiology (ESC) released the latest version of its guidelines for managing ...
September 06, 2011
August 18, 2011 — The antiplatelet agent prasugrel (trade name Effient), in combination with aspirin, was associated ...
August 19, 2011Aug. 2, 2011 — New York University (NYU) Langone Medical Center received an $84 million grant from the National Heart ...
August 02, 2011
July 21, 2011 – The U.S. Food and Drug Administration (FDA) today approved AstraZeneca’s blood-thinning drug ticagrelor ...
July 21, 2011